Sangamo Therapeutics(SGMO)
搜索文档
Sangamo Therapeutics(SGMO) - 2021 Q1 - Earnings Call Presentation
2021-05-05 06:01
Corporate Presentation May 2021 Forward-Looking Statements This presentation contains forward-looking statements regarding our current expectations. These forward-looking statements include, without limitation, statements relating to the potential to develop, obtain regulatory approvals for and commercialize safe and effective therapies to treat certain diseases and the timing, availability and costs of such therapies, the potential to use ZFP, ZFP-TF, ZFN, ZFP-Epi, CAR-Treg and other technologies to develo ...
Sangamo Therapeutics (SGMO) Presents At SVB Leerink 10th Annual Global Healthcare Conference - Slideshow
2021-02-27 07:38
Corporate Presentation February 2021 Forward-Looking Statements This presentation contains forward-looking statements regarding our current expectations. These forward-looking statements include, without limitation, statements relating to the potential to develop, obtain regulatory approvals for and commercialize safe and effective therapies to treat certain diseases and the timing, availability and costs of such therapies, the potential to use ZFP, ZFP-TF, ZFN, ZFP-Epi, CAR-Treg and other technologies to d ...
Sangamo Therapeutics(SGMO) - 2020 Q4 - Earnings Call Transcript
2021-02-25 12:45
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2020 Earnings Conference Call February 24, 2021 5:00 PM ET Company Participants Aron Feingold - Head of Corporate Communications Sandy Macrae - Chief Executive Officer Bettina Cockroft - Senior Vice President and Chief Medical Officer Jason Fontenot - Senior Vice President, Chief Scientific Officer Mark McClung - Executive Vice President and Chief Business Officer Rob Schott - Senior Vice President and Head of Development. Conference Call Participants Maurice Rayc ...
Sangamo Therapeutics (SGMO) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow
2021-01-20 05:54
| --- | --- | |-----------------------------------|-------| | | | | | | | | | | Corporate Presentation | | | | | | | | | J.P. Morgan Healthcare Conference | | | Sandy Macrae, CEO | | | January 13, 2021 | | Forward-Looking Statements This presentation contains forward-looking statements regarding our current expectations. These forward-looking statements include, without limitation, statements relating to the potential to develop, obtain regulatory approvals for and commercialize safe and effective therapies ...